TP53 and melanoma: Previous studies have linked UBL5 to melanoma growth as deubiquitinating enzymes (DUBs) [34], while depletion of SRSF3 leads to a switch in MDM4 splicing that influences p53-mediated antiproliferative activity [35,36].